Updated Meta-analysis of the TP53 Arg72Pro Polymorphism and Gastric Cancer Risk |
Xiang, Bin
(Department of Gastroenterology, the Affiliated Jiangyin Hospital of Southeast University Medical School)
Mi, Yuan-Yuan (The Third Affiliated Hospital of Nantong University) Li, Teng-Fei (Department of Gastroenterology, the Affiliated Jiangyin Hospital of Southeast University Medical School) Liu, Peng-Fei (Department of Gastroenterology, the Affiliated Jiangyin Hospital of Southeast University Medical School) |
1 | Bergamaschi D, Gasco M, Hiller L, et al (2003). p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis. Cancer Cell, 3, 387-402. DOI ScienceOn |
2 | Birgander R, Sjalander A, Zhou Z, et al (1996). p53 polymorphisms and haplotypes in nasopharyngeal cancer. Hum Hered, 46, 49-54. DOI |
3 | Capella G, Pera G, Sala N, et al (2008). DNA repair polymorphisms and the risk of stomach adenocarcinoma and severe chronic gastritis in the EPIC-EURGAST study. Int J Epidemiol, 37, 1316-25. DOI |
4 | De Feo E, Persiani R, La Greca A, et al (2009). A case-control study on the effect of p53 and p73 gene polymorphisms on gastric cancer risk and progression. Mutat Res, 675, 60-5. DOI ScienceOn |
5 | DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88. DOI |
6 | Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in metaanalysis detected by a simple, graphical test. BMJ, 315, 629-34. DOI |
7 | Etienne MC, Chazal M, Laurent-Puig P, et al (2002). Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: phenotypic and genotypic analyses. J Clin Oncol, 20, 2832-43. DOI ScienceOn |
8 | Gao L, Nieters A, Brenner H (2009). Cell proliferation-related genetic polymorphisms and gastric cancer risk: systematic review and meta-analysis. Eur J Hum Genet, 17, 1658-67. DOI ScienceOn |
9 | Gomes de Souza L, Miranda de Lima J, Dale Cotrim Guerreiro da Silva I, Manoukian Forones N (2009). P53 Arg72Pro polymorphism in gastric cancer patients. J Gastrointest Cancer, 40, 41-5. DOI |
10 | Hamajima N, Matsuo K, Suzuki T, et al (2002). No associations of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro polymorphisms with the risk of digestive tract cancers in Japanese. Cancer Lett, 181, 81-5. DOI |
11 | Hiyama T, Tanaka S, Kitadai Y, et al (2002). p53 Codon 72 polymorphism in gastric cancer susceptibility in patients with Helicobacter pylori-associated chronic gastritis. Int J Cancer, 100, 304-8. DOI ScienceOn |
12 | Ihsan R, Devi TR, Yadav DS, et al (2011). Investigation on the role of p53 codon 72 polymorphism and interactions with tobacco, betel quid, and alcohol in susceptibility to cancers in a high-risk population from North East India. DNA Cell Biol, 30, 163-71. DOI ScienceOn |
13 | Lai KC, Chen WC, Tsai FJ, Li SY, Jeng LB (2005). Arginine and proline alleles of the p53 gene are associated with different locations of gastric cancer. Hepatogastroenterology, 52, 944-8. |
14 | Katkoori VR, Jia X, Shanmugam C, et al (2009). Prognostic significance of p53 codon 72 polymorphism differs with race in colorectal adenocarcinoma. Clin Cancer Res, 15, 2406-16. DOI ScienceOn |
15 | Ke-Xiang Z, Yu-Min L, Xun L, et al (2012). Study on the association of p53 codon 72 polymorphisms with risk of gastric cancer in high incidence Hexi area of Gansu Province in China. Mol Biol Rep, 39, 723-8. DOI |
16 | Kim N, Cho SI, Lee HS, et al (2010). The discrepancy between genetic polymorphism of p53 codon 72 and the expression of p53 protein in Helicobacter pylori-associated gastric cancer in Korea. Dig Dis Sci, 55, 101-10. DOI |
17 | Lane DP (1992). Cancer. p53, guardian of the genome. Nature, 358, 15-6. DOI ScienceOn |
18 | Levine AJ (1997). p53, the cellular gatekeeper for growth and division. Cell, 88, 323-31. DOI ScienceOn |
19 | Li Y, Prives C (2007). Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function? Oncogene, 26, 2220-5. DOI |
20 | Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48. |
21 | Mojtahedi Z, Haghshenas MR, Hosseini SV, Fattahi MJ, Ghaderi A (2010). p 53 codon 72 polymorphism in stomach and colorectal adenocarcinomas in Iranian patients. Indian J Cancer, 47, 31-4. DOI ScienceOn |
22 | Mu LN, Lu QY, Yu SZ, et al (2005). Green tea drinking and multigenetic index on the risk of stomach cancer in a Chinese population. Int J Cancer, 116, 972-83. DOI |
23 | Shen H, Solari A, Wang X, et al (2004). P53 codon 72 polymorphism and risk of gastric cancer in a Chinese population. Oncol Rep, 11, 1115-20. |
24 | Papadakis EN, Dokianakis DN, Spandidos DA (2000). p53 codon 72 polymorphism as a risk factor in the development of breast cancer. Mol Cell Biol Res Commun, 3, 389-92. DOI ScienceOn |
25 | Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. DOI ScienceOn |
26 | Perez-Perez GI, Bosques-Padilla FJ, Crosatti ML, Tijerina-Menchaca R, Garza-Gonzalez E (2005). Role of p53 codon 72 polymorphism in the risk of development of distal gastric cancer. Scand J Gastroenterol, 40, 56-60. DOI |
27 | Shepherd T, Tolbert D, Benedetti J, et al (2002). Alterations in exon 4 of the p53 gene in gastric carcinoma. Gastroenterology, 118, 1039-44. |
28 | Shirai O, Ohmiya N, Taguchi A, et al (2010). P53, p21, and p73 gene polymorphisms in gastric carcinoma. Hepatogastroenterology, 57, 1595-601. |
29 | Sjalander A, Birgander R, Hallmans G, et al (1997). p53 polymorphisms and haplotypes in breast cancer. Carcinogenesis, 17, 1313-6. |
30 | Song HR, Kweon SS, Kim HN, et al (2011). p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population. Gastric Cancer, 14, 242-8. DOI |
31 | Sul J, Yu GP, Lu QY, et al (2006). P53 Codon 72 polymorphisms: a case-control study of gastric cancer and potential interactions. Cancer Lett, 238, 210-23. DOI ScienceOn |
32 | Thomas M, Kalita A, Labrecque S, et al (1999). Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol, 19, 1092-100. DOI |
33 | Vogelstein B, Lane D, Levine AJ (2002). Surfing the p53 network. Nature, 408, 307-10. |
34 | Wu MT, Chen MC, Wu DC (2004). Influences of lifestyle habits and p53 codon 72 and p21 codon 31 polymorphisms on gastric cancer risk in Taiwan. Cancer Lett, 205, 61-8. DOI ScienceOn |
35 | Vousden KH, Lane DP (2007). p53 in health and disease. Nat Rev Mol Cell Biol, 8, 275-83. DOI |
36 | Walker KK, Levine AJ (1996). Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc Natl Acad Sci USA, 93, 15335-40. DOI ScienceOn |
37 | Wang YC, Lee HS, Chen SK, Chang YY, Chen CY (1999). Prognostic significance of p53 codon 72 polymorphism in lung carcinomas. Eur J Cancer, 35, 226-30. DOI ScienceOn |
38 | Xi YG, Ding KY, Su XL, et al (2004). p53 polymorphism and p21WAF1/CIP1 haplotype in the intestinal gastric cancer and the precancerous lesions. Carcinogenesis, 25, 2201-6. DOI ScienceOn |
39 | Yi SY, Lee WJ (2006). A p53 genetic polymorphism of gastric cancer: difference between early gastric cancer and advanced gastric cancer. World J Gastroenterol, 12, 6536-9. DOI |
40 | Zhang ZW, Newcomb P, Hollowood A, et al (2003). Ageassociated increase of codon 72 Arginine p53 frequency in gastric cardia and non-cardia adenocarcinoma. Clin Cancer Res, 9, 2151-6. |
41 | Zhang ZW, Newcomb P, Hollowood A, et al (2004). A comparison study of gastric cancer risk in patients with duodenal and gastric ulcer: roles of gastric mucosal histology and p53 codon 72 polymorphism. Dig Dis Sci, 49, 254-9. DOI |
42 | Zhou Y, Li N, Zhuang W, et al (2007). P53 codon 72 polymorphism and gastric cancer: a meta-analysis of the literature. Int J Cancer, 121, 1481-6. DOI ScienceOn |